Back
Spyre Therapeutics, Inc. Stock Price Chart
$10K Investment in Nvidia Could've Made $2.5M
DISCLOSURE: This is a paid advertisement for RAD Intel's Reg A offering and involves risk, including the possible loss of principal. Please read the offering circular and related risks at invest.radi
Buy
53
SYRE
Spyre Therapeutics, Inc.
Last Price:
$35.13
Seasonality Move:
-3.15%
7 Day Trial
ALL ACCESS PASS
$
7
When an AI Platform Gets Pulled by Too Much Demand
DISCLOSURE: This is a paid advertisement for RAD Intel's Reg A offering and involves risk, including the possible loss of principal. Please read the offering circular and related risks at invest.radi-
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and SYRE is experiencing buying pressure, which is a positive indicator for future bullish movement.
Spyre Therapeutics, Inc. Price Chart Indicators
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 33.11 | Buy |
| 20-day SMA: | 32.94 | Buy |
| 50-day SMA: | 32.48 | Buy |
| 200-day SMA: | 21.23 | Buy |
| 8-day EMA: | 25.98 | Buy |
| 20-day EMA: | 14.97 | Buy |
| 50-day EMA: | 7.06 | Buy |
| 200-day EMA: | 1.92 | Buy |
Spyre Therapeutics, Inc. Technical Analysis Indicators
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 8.79 | Buy |
| Relative Strength Index (14 RSI): | 60.77 | Buy |
| Chaikin Money Flow: | 721134 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (31.08 - 33.78) | Buy |
| Bollinger Bands (100): | (20.04 - 33.1) | Buy |
Spyre Therapeutics, Inc. Technical Analysis
| Jan 26 | Jan 27 | Jan 28 | Jan 29 | Jan 30 | Feb 2 | Feb 3 | Feb 4 | Feb 5 | Feb 6 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Jan | Feb | |||||||||
| 26 | 27 | 28 | 29 | 30 | 02 | 03 | 04 | 05 | 06 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Technical Analysis for Spyre Therapeutics, Inc. Stock
Is Spyre Therapeutics, Inc. Stock a Buy?
-
Spyre Therapeutics, Inc. share price is 35.12 while SYRE 8-day simple moving average is 33.11, which is a Buy signal.
-
The stock price of SYRE is 35.12 while Spyre Therapeutics, Inc. 20-day SMA is 32.94, which makes it a Buy.
-
Spyre Therapeutics, Inc. 50-day simple moving average is 32.48 while SYRE share price is 35.12, making it a Buy technically.
-
SYRE stock price is 35.12 and Spyre Therapeutics, Inc. 200-day simple moving average is 21.23, creating a Buy signal.
SYRE Technical Analysis vs Fundamental Analysis
Buy
53
Spyre Therapeutics, Inc. (SYRE)
is a Buy
Is Spyre Therapeutics, Inc. a Buy or a Sell?
-
Spyre Therapeutics, Inc. stock is rated a BuyThe current Spyre Therapeutics, Inc. [SYRE] share price is $35.12. The Score for SYRE is 53, which is 6% above its historic median score of 50, and infers lower risk than normal.
Spyre Therapeutics, Inc. Stock Info
Market Cap:
2.7B
Price in USD:
35.12
Share Volume:
790.5K
Spyre Therapeutics, Inc. 52-Week Range
52-Week High:
35.31
52-Week Low:
10.91
Buy
53
Spyre Therapeutics, Inc. (SYRE)
is a Buy
Spyre Therapeutics, Inc. Share Price Forecast
-
What is the Spyre Therapeutics, Inc. stock price today?The Spyre Therapeutics, Inc. stock price is 35.12 USD today.
-
Will SYRE stock go up or go down?Spyre Therapeutics, Inc.> share price is forecast to RISE/FALL based on technical indicators
-
Is Spyre Therapeutics, Inc. overvalued?According to simple moving average, exponential moving average, oscillators, and other technical indicators, Spyre Therapeutics, Inc. is not overvalued.
Is Spyre Therapeutics, Inc. Stock a Buy?
-
Spyre Therapeutics, Inc. share price is 35.12 while SYRE 8-day exponential moving average is 25.98, which is a Buy signal.
-
The stock price of SYRE is 35.12 while Spyre Therapeutics, Inc. 20-day EMA is 14.97, which makes it a Buy.
-
Spyre Therapeutics, Inc. 50-day exponential moving average is 7.06 while SYRE share price is 35.12, making it a Buy technically.
-
SYRE stock price is 35.12 and Spyre Therapeutics, Inc. 200-day simple moving average is 1.92, creating a Buy signal.
Fundamental Analysis of Spyre Therapeutics, Inc.
Is Spyre Therapeutics, Inc. a good investment?
-
Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.68 per share, and a decrease next year of $0.05 per share.
Technical Analysis of Spyre Therapeutics, Inc.
Should I short Spyre Therapeutics, Inc. stock?
-
SYRE Moving Average Covergence Divergence (MACD) indicator is 8.79, suggesting Spyre Therapeutics, Inc. is a Buy
-
Spyre Therapeutics, Inc. Relative Strength Index (RSI) is 60.77, which suggest Spyre Therapeutics, Inc. is overbought
-
The Bollinger Bands (25) for Spyre Therapeutics, Inc. is (31.08 - 33.78), which suggest Spyre Therapeutics, Inc. is a Buy
-
The Bollinger Bands (100) for Spyre Therapeutics, Inc. is (20.04 - 33.1), which suggest Spyre Therapeutics, Inc. is a Buy
* Spyre Therapeutics, Inc. stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.